409 related articles for article (PubMed ID: 35517803)
1. Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials.
Feng Q; Yu X; Qiao Y; Pan S; Wang R; Zheng B; Wang H; Ren KD; Liu H; Yang Y
Front Pharmacol; 2022; 13():858676. PubMed ID: 35517803
[TBL] [Abstract][Full Text] [Related]
2. Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases.
Feng Q; Yang Y; Ren K; Qiao Y; Sun Z; Pan S; Liu F; Liu Y; Huo J; Liu D; Liu Z
Int J Biol Sci; 2023; 19(12):3726-3743. PubMed ID: 37564215
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis: A new insight for treatment of acute kidney injury.
Li S; Wang R; Wang Y; Liu Y; Qiao Y; Li P; Chen J; Pan S; Feng Q; Liu Z; Liu D
Front Pharmacol; 2022; 13():1065867. PubMed ID: 36467031
[TBL] [Abstract][Full Text] [Related]
4. Emerging Role of Ferroptosis in Acute Kidney Injury.
Hu Z; Zhang H; Yang SK; Wu X; He D; Cao K; Zhang W
Oxid Med Cell Longev; 2019; 2019():8010614. PubMed ID: 31781351
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment.
Qiao O; Wang X; Wang Y; Li N; Gong Y
J Adv Res; 2023 Dec; 54():211-222. PubMed ID: 36702249
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis: A Potential Therapeutic Target in Acute Kidney Injury.
Hosohata K; Harnsirikarn T; Chokesuwattanaskul S
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743026
[TBL] [Abstract][Full Text] [Related]
7. Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities.
Wang H; Liu D; Zheng B; Yang Y; Qiao Y; Li S; Pan S; Liu Y; Feng Q; Liu Z
Int J Biol Sci; 2023; 19(9):2678-2694. PubMed ID: 37324941
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis: A new mechanism of traditional Chinese medicine compounds for treating acute kidney injury.
Shi Y; Shi X; Zhao M; Chang M; Ma S; Zhang Y
Biomed Pharmacother; 2023 Jul; 163():114849. PubMed ID: 37172334
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of Ferroptosis and Their Involvement in Acute Kidney Injury.
Liu J; Han X; Zhou J; Leng Y
J Inflamm Res; 2023; 16():4941-4951. PubMed ID: 37936596
[TBL] [Abstract][Full Text] [Related]
10. The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis.
Guo R; Duan J; Pan S; Cheng F; Qiao Y; Feng Q; Liu D; Liu Z
Cell Death Dis; 2023 Jul; 14(7):426. PubMed ID: 37443140
[TBL] [Abstract][Full Text] [Related]
11. Paeoniflorin alleviates ischemia/reperfusion induced acute kidney injury by inhibiting Slc7a11-mediated ferroptosis.
Ma L; Liu X; Zhang M; Zhou L; Jiang L; Gao L; Wang X; Huang Y; Zeng H; Wu Y
Int Immunopharmacol; 2023 Mar; 116():109754. PubMed ID: 36753983
[TBL] [Abstract][Full Text] [Related]
12. Targeting ferroptosis in acute kidney injury.
Ni L; Yuan C; Wu X
Cell Death Dis; 2022 Feb; 13(2):182. PubMed ID: 35210424
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Targeted Antioxidant SKQ1 Ameliorates Acute Kidney Injury by Inhibiting Ferroptosis.
Song J; Sheng J; Lei J; Gan W; Yang Y
Oxid Med Cell Longev; 2022; 2022():2223957. PubMed ID: 36193064
[TBL] [Abstract][Full Text] [Related]
14. CD36 promotes tubular ferroptosis by regulating the ubiquitination of FSP1 in acute kidney injury.
Ma Y; Huang L; Zhang Z; Yang P; Chen Q; Zeng X; Tan F; Wang C; Ruan X; Liao X
Genes Dis; 2024 Jan; 11(1):449-463. PubMed ID: 37588197
[TBL] [Abstract][Full Text] [Related]
15. A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives.
Han Z; Luo Y; Chen H; Zhang G; You L; Zhang M; Lin Y; Yuan L; Zhou S
Kidney Dis (Basel); 2024 Jun; 10(3):224-236. PubMed ID: 38835406
[TBL] [Abstract][Full Text] [Related]
16. Dietary docosahexaenoic acid plays an opposed role in ferroptotic and non-ferroptotic acute kidney injury.
Shan K; Li J; Yang Q; Chen K; Zhou S; Jia L; Fu G; Qi Y; Wang Q; Chen YQ
J Nutr Biochem; 2023 Oct; 120():109418. PubMed ID: 37490984
[TBL] [Abstract][Full Text] [Related]
17. Iron, ferroptosis, and new insights for prevention in acute kidney injury.
Borawski B; Malyszko J
Adv Med Sci; 2020 Sep; 65(2):361-370. PubMed ID: 32592957
[TBL] [Abstract][Full Text] [Related]
18. Targeting ferroptosis in ischemia/reperfusion renal injury.
Thapa K; Singh TG; Kaur A
Naunyn Schmiedebergs Arch Pharmacol; 2022 Nov; 395(11):1331-1341. PubMed ID: 35920897
[TBL] [Abstract][Full Text] [Related]
19. Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers.
Mishima E; Sato E; Ito J; Yamada KI; Suzuki C; Oikawa Y; Matsuhashi T; Kikuchi K; Toyohara T; Suzuki T; Ito S; Nakagawa K; Abe T
J Am Soc Nephrol; 2020 Feb; 31(2):280-296. PubMed ID: 31767624
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid-Induced AKI.
Martin-Sanchez D; Ruiz-Andres O; Poveda J; Carrasco S; Cannata-Ortiz P; Sanchez-Niño MD; Ruiz Ortega M; Egido J; Linkermann A; Ortiz A; Sanz AB
J Am Soc Nephrol; 2017 Jan; 28(1):218-229. PubMed ID: 27352622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
